ZNO Zoono Group Limited
Consumer Defensive · Household & Personal Products
· website
$0.05
52wk 0.03 – 0.17
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About Zoono Group Limited
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand, Australasia, Asia, the United States, India, the United Kingdom, and Europe. It offers hand and surface sanitisers, textile applicator, and mould remediation products. Zoono Group Limited was founded in 2007 and is headquartered in Auckland, New Zealand.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$19.90M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
1.21
EV / EBITDA
-5.95
Price / Book
5.96
ROE
-78.4%
Operating margin
-205.0%
Net margin
0.0%
Total cash
$551,207
Total debt
$426,536
Current ratio
5.00
Debt / Equity
0.11
Free cash flow
$-286,219
Avg volume
83,513
Latest annual results
(FY ending 30 Jun 2024)
- Revenue$960.30K
- Gross profit$251.07K
- Operating income-$3.72M
- Net income-$8.32M
- Diluted EPS-0.04
- Free cash flow-$2.89M
- Net debt-$1.07M